Dreaming the possible

hiPSCs for predictive modelling of neurodegenerative diseases

Announcements

Advertisement

Treatment of multiple sclerosis

Treatment of multiple sclerosis

The first disease-modifying therapy for relapsing–remitting multiple sclerosis — interferon‑β 1b — was approved by the FDA in 1993. The following 25 years have seen rapid expansion of the therapeutic options as an evolving understanding of the disease has enabled development of therapies with different modes of action.
Milestone

Nature Careers

Events